Xlumena, Inc., has announced it has closed $25 million in Series C financing.

Xlumena, headquartered in Mountain View, Calif., is a developer of image-guided therapeutic endoscopy products.

The financing round included existing investors Prism VentureWorks, Charter Life Sciences, Ascent Biomedical Ventures and Aperture Venture Partners. 

Xlumena indicated it will use the proceeds to support efforts to expand global commercialization for its AXIOS family of devices and bring the platform to the U.S.